Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2013-04-29

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm400204kPMID 23570514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.

  2013cited by this paper
• Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2.

  2012cited by this paper
• 5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors.

  2012cited by this paper
• The NAD-dependent deacetylase SIRT2 is required for programmed necrosis

  2012cited by this paper
• Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors

  2012cited by this paper
• Sirtuin 2 (SIRT2) Enhances 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Nigrostriatal Damage via Deacetylating Forkhead Box O3a (Foxo3a) and Activating Bim Protein*

  2012cited by this paper
• Are sirtuins viable targets for improving healthspan and lifespan?

  2012cited by this paper
• Synthesis of carba-NAD and the structures of its ternary complexes with SIRT3 and SIRT5.

  2012cited by this paper
• Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT).

  2012cited by this paper
• Physicochemical profile of macrolides and their comparison with small molecules.

  2012cited by this paper
• Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.

  2011cited by this paper
• SIRT1 modulation as a novel approach to the treatment of diseases of aging.

  2011cited by this paper
• Overview of the CCP4 suite and current developments

  2011cited by this paper
• SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity.

  2010cited by this paper
• SIRT1 Activation by Small Molecules

  2010cited by this paper
• SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2

  2010cited by this paper
• Structural basis for sirtuin function: what we know and what we don't.

  2010cited by this paper
• xia2: an expert system for macromolecular crystallography data reduction

  2010cited by this paper
• Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.

  2009cited by this paper
• Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

  2009cited by this paper
• Identification and characterization of novel sirtuin inhibitor scaffolds.

  2009cited by this paper
• Sirt1’s Complex Roles in Neuroprotection

  2009cited by this paper
• Recent progress in the biology and physiology of sirtuins

  2009cited by this paper
• Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes

  2009cited by this paper
• N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.

  2009cited by this paper
• Design, synthesis and selection of DNA-encoded small-molecule libraries.

  2009cited by this paper
• SirT1 gain of function increases energy efficiency and prevents diabetes in mice.

  2008cited by this paper
• Tissue-specific regulation of SIRT1 by calorie restriction.

  2008cited by this paper
• SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes

  2008cited by this paper
• Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

  2008cited by this paper
• Phaser crystallographic software

  2007cited by this paper
• Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins)

  2007cited by this paper
• Sirtuin 2 Inhibitors Rescue α-Synuclein-Mediated Toxicity in Models of Parkinson's Disease

  2007cited by this paper
• Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.

  2007cited by this paper
• Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.

  2006cited by this paper
• Scaling and assessment of data quality.

  2006cited by this paper
• Discovering inhibitors of human sirtuin type 2: novel structural scaffolds.

  2006cited by this paper
• Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.

  2005cited by this paper
• Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Structure of the histone deacetylase SIRT2

  2001cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper

• A medicinal chemistry perspective on SIRT3 modulators in disease treatment.

  2026cites this paper
• Discovery of novel SIRT2 inhibitors with anti-NSCLC activity through multi-virtual screening and biological evaluation.

  2025cites this paper
• Sirtuin 3 as a promising target in disease therapy: Model action and drug discovery.

  2025cites this paper
• Screening of SIRT2 inhibitors from natural product databases using computer-aided drug design and molecular dynamics simulation

  2025cites this paper
• Computational Design and Synthesis of Phthalimide Derivatives as TGF-β Pathway Inhibitors for Cancer Therapeutics

  2025cites this paper
• 2-(Diarylalkyl)aminobenzothiazole derivatives induce autophagy and apoptotic death through SIRT inhibition and P53 activation In MCF7 breast cancer cells

  2025cites this paper
• Multicomponent reactions (MCRs) yielding medicinally relevant rings: a recent update and chemical space analysis of the scaffolds

  2025cites this paper
• New insight into molecular mechanisms of different polyphenols affecting Sirtuin 3 deacetylation activity.

  2024cites this paper
• Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective

  2024cites this paper
• Context-dependent role of SIRT3 in cancer.

  2024cites this paper
• Exploring the landscape of post-translational modification in drug discovery.

  2024cites this paper
• Epigenetics-targeted drugs: current paradigms and future challenges

  2024cites this paper
• Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity.

  2024cites this paper
• Research progress on Sirtuins (SIRTs) family modulators.

  2024cites this paper
• Identification of phytoestrogens as sirtuin inhibitor against breast cancer: Multitargeted approach

  2024cites this paper
• Current Trends in Sirtuin Activator and Inhibitor Development

  2024cites this paper
• Activation and inhibition of sirtuins: From bench to bedside

  2024cites this paper
• Sirtuin insights: bridging the gap between cellular processes and therapeutic applications

  2024cites this paper
• Mitochondrial sirtuin 3 and role of natural compounds: the effect of post-translational modifications on cellular metabolism

  2024cites this paper
• The roles of sirtuins in ferroptosis

  2023influential citation
• Human sirtuin 2 inhibitors, their mechanisms and binding modes.

  2023cites this paper
• Discovery of Novel SIRT1/2 Inhibitors with Effective Cytotoxicity against Human Leukemia Cells

  2023cites this paper
• AI-Powered Virtual Screening of Large Compound Libraries Leads to the Discovery of Novel Inhibitors of Sirtuin-1.

  2023cites this paper
• Discovery of a pyrrole-pyridinimidazole derivative as novel SIRT6 inhibitor for sensitizing pancreatic cancer to gemcitabine

  2023cites this paper
• Identification of novel scaffolds targeting SIRT3 through molecular modeling techniques for the treatment of Hepatocellular carcinoma

  2023cites this paper
• Discovery of Novel N -Acylhydrazone Derivatives as Potent Inhibitors of Sirtuin-1

  2023cites this paper
• The Role of Histone Deacetylases in Acute Lung Injury—Friend or Foe

  2023cites this paper
• Discovery and design of dual inhibitors targeting Sphk1 and Sirt1

  2023cites this paper
• Sirtuin1-p53: a potential axis for cancer therapy.

  2023cites this paper
• DNA-Compatible Suzuki-Miyaura Cross-Coupling Reaction of Aryl Iodides With (Hetero)Aryl Boronic Acids for DNA-Encoded Libraries

  2022cites this paper
• Small Changes Make the Difference for SIRT2: Two Different Binding Modes for 3-Arylmercapto-Acylated Lysine Derivatives.

  2022cites this paper
• Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4′,5′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines on the Basis of pyrano[3,4-c]pyridines

  2022cites this paper
• Sirtuin modulators: past, present, and future perspectives.

  2022cites this paper
• Discovery of novel compounds as potent activators of Sirt3

  2022cites this paper
• Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors

  2022cites this paper
• Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity.

  2022cites this paper
• The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications

  2022influential citation
• Exploration of stilbenoid trimers as potential inhibitors of sirtuin1 enzyme using a molecular docking and molecular dynamics simulation approach

  2021cites this paper
• Rational design and development of HDAC inhibitors for breast cancer treatment.

  2021cites this paper
• High‐Throughput Screening Identifies Ascorbyl Palmitate as a SIRT2 Deacetylase and Defatty‐Acylase Inhibitor

  2021cites this paper
• Structural alterations in the catalytic core of hSIRT2 enzyme predict therapeutic bene fi ts of Garcinia mangostana derivatives in Alzheimer's disease: molecular dynamics simulation study † RSC Advances PAPER

  2021cites this paper
• Medicinal chemistry of histone deacetylase inhibitors

  2021cites this paper
• Structural alterations in the catalytic core of hSIRT2 enzyme predict therapeutic benefits of Garcinia mangostana derivatives in Alzheimer's disease: molecular dynamics simulation study

  2021cites this paper
• Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library.

  2021cites this paper
• SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

  2021cites this paper
• Discovery of soluble epoxide hydrolase inhibitors through DNA-encoded library technology (ELT).

  2021cites this paper
• Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry.

  2021cites this paper
• High-power screening (HPS) empowered by DNA-encoded libraries.

  2021cites this paper
• The conflicting role of SIRT3 as therapeutic target in cancer

  2021cites this paper
• Unexpected small molecules as novel SIRT2 suicide inhibitors.

  2020cites this paper
• DNA-Compatible Copper-Catalyzed Oxidative Amidation of Aldehydes with Non-Nucleophilic Arylamines.

  2020cites this paper
• Synthesis of indole inhibitors of silent information regulator 1 (SIRT1), and their evaluation as cytotoxic agents.

  2020cites this paper
• Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target

  2020influential citation
• Design, Synthesis, and Biological Evaluation of 8-Mercapto-3,7-Dihydro-1H-Purine-2,6-Diones as Potent Inhibitors of SIRT1, SIRT2, SIRT3, and SIRT5

  2020cites this paper
• Emerging Role of Sirtuins in Breast Cancer Metastasis and Multidrug resistance: Implication for Novel Therapeutic Strategies Targeting Sirtuins.

  2020cites this paper
• A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring Nε-thioacetyl-lysine.

  2020cites this paper
• An overview of DNA-encoded libraries: A versatile tool for drug discovery.

  2020cites this paper
• Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)

  2020cites this paper
• Design and Synthesis of Amino Acid Derivatives of Substituted Benzimidazoles and Pyrazoles as Selective Sirt1 Inhibitors

  2020cites this paper
• Unraveling the Unbinding Pathways of Products Formed in Catalytic Reactions Involved in SIRT1-3: A Random Acceleration Molecular Dynamics Simulation Study

  2019cites this paper
• A Comparative Linear Interaction Energy and MM/PBSA Study on SIRT1–Ligand Binding Free Energy Calculation

  2019cites this paper
• Patrícia Crespo Braga SIRT 1 and energy metabolism in rodent Sertoli cells

  2019cites this paper
• Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs

  2019cites this paper
• Open-Air Alkylation Reactions in Photoredox-Catalyzed DNA-Encoded Library Synthesis.

  2019cites this paper
• Crystallographic and SAR analyses reveal the high requirements needed to selectively and potently inhibit SIRT2 deacetylase and decanoylase.

  2019cites this paper
• Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors.

  2019cites this paper
• Epigenetic Tools in Chronic Pain Studies

  2019cites this paper
• A prospective compound screening contest identified broader inhibitors for Sirtuin 1

  2019cites this paper
• The Roles of Sirtuin Family Proteins in Cancer Progression

  2019cites this paper
• Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors.

  2019cites this paper
• Discovery of gamma-mangostin from Garcinia mangostana as a potent and selective natural SIRT2 inhibitor.

  2019cites this paper
• Structure-Based Design of Epigenetic Inhibitors

  2019cites this paper
• Sirtuins in Multiple Sclerosis: The crossroad of neurodegeneration, autoimmunity and metabolism.

  2019cites this paper
• Scalable and Straightforward Synthesis of All Isomeric (Cyclo)alkylpiperidines

  2019cites this paper
• Sirtuins as Drug Targets

  2019cites this paper
• Computer‐based Lead Identification for Epigenetic Targets

  2019cites this paper
• Sirtuin Inhibitors and Activators

  2019cites this paper
• Applicability and performance of linear interaction energy based binding affinity calculation

  2019cites this paper
• Recent advances in inhibitors of sirtuin1/2: an update and perspective.

  2018cites this paper
• X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.

  2018cites this paper
• Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics.

  2018cites this paper
• Sirtuin activators and inhibitors: Promises, achievements, and challenges.

  2018influential citation
• In vitro study of in silico designed sirtuin 1 and bromodomain 4 inhibitors on human neuroblastoma SH-SY5Y and acute myeloid leukemia U937 cells

  2018cites this paper
• DNA-NH2 acylation reaction: Molecular weight or conformation dominates?

  2018cites this paper
• 2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

  2018cites this paper
• Exploration of the Fluorescent Properties and the Modulated Activities against Sirtuin Fluorogenic Assays of Chromenone-Derived Natural Products

  2018cites this paper
• The Current State of NAD+‐Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets

  2018cites this paper
• Targeting Sirtuins: Substrate Specificity and Inhibitor Design.

  2018cites this paper
• Crystal structure of Sirt2 in complex with selective inhibitor A2I

  2018cites this paper
• Sirt3 enhances glioma cell viability by stabilizing Ku70–BAX interaction

  2018cites this paper
• Design, Synthesis and Anti-Proliferative Activities of 2,6-Substituted Thieno[3,2-d]pyrimidine Derivatives Containing Electrophilic Warheads

  2017cites this paper
• Access to functionalized thienopyridines via a reagent-capsule-assisted coupling, thiolation and cyclization cascade sequence.

  2017cites this paper
• Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors

  2017cites this paper
• Use of the Monte Carlo Method for OECD Principles‐Guided QSAR Modeling of SIRT1 Inhibitors

  2017cites this paper
• The Role of Sirtuins in Antioxidant and Redox Signaling

  2017cites this paper
• An Integrated Microfluidic Processor for DNA-Encoded Combinatorial Library Functional Screening

  2017cites this paper
• Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening

  2017cites this paper
• High-throughput Identification of DNA-Encoded IgG Ligands that Distinguish Active and Latent Mycobacterium tuberculosis Infections.

  2017cites this paper
• Recent advances on the encoding and selection methods of DNA-encoded chemical library.

  2017cites this paper
• Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors.

  2017cites this paper